143 related articles for article (PubMed ID: 25856663)
1. Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods.
Kristensen V; Lauritzen T; Jelsness-JØrgensen LP; Moum B
Scand J Clin Lab Invest; 2015 Sep; 75(5):355-61. PubMed ID: 25856663
[TBL] [Abstract][Full Text] [Related]
2. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B
Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
[TBL] [Abstract][Full Text] [Related]
3. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
4. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
[TBL] [Abstract][Full Text] [Related]
5. Patient-performed extraction of faecal calprotectin.
Kristensen V; Lauritzen T; Jelsness-Jørgensen LP; Frigstad SO; Corwin C; Moum B
Clin Chem Lab Med; 2016 Aug; 54(8):1357-63. PubMed ID: 26812797
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
[TBL] [Abstract][Full Text] [Related]
7. Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method.
Coorevits L; Baert FJ; Vanpoucke HJ
Clin Chem Lab Med; 2013 Apr; 51(4):825-31. PubMed ID: 23001318
[TBL] [Abstract][Full Text] [Related]
8. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
Gisbert JP; McNicholl AG
Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
[TBL] [Abstract][Full Text] [Related]
9. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
Summerton CB; Longlands MG; Wiener K; Shreeve DR
Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
[TBL] [Abstract][Full Text] [Related]
10. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
Sydora MJ; Sydora BC; Fedorak RN
J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
[TBL] [Abstract][Full Text] [Related]
11. Faecal calprotectin: a new marker for Crohn's disease?
Wassell J; Dolwani S; Metzner M; Losty H; Hawthorne A
Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
[TBL] [Abstract][Full Text] [Related]
12. Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits.
Whitehead SJ; French J; Brookes MJ; Ford C; Gama R
Ann Clin Biochem; 2013 Jan; 50(Pt 1):53-61. PubMed ID: 23129721
[TBL] [Abstract][Full Text] [Related]
13. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
[TBL] [Abstract][Full Text] [Related]
14. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
Røseth AG; Aadland E; Grzyb K
Scand J Gastroenterol; 2004 Oct; 39(10):1017-20. PubMed ID: 15513345
[No Abstract] [Full Text] [Related]
15. Comparative study of a new quantitative rapid test with an established ELISA method for faecal calprotectin.
Dolci A; Panteghini M
Clin Chim Acta; 2012 Jan; 413(1-2):350-1. PubMed ID: 21982915
[No Abstract] [Full Text] [Related]
16. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
Schröder O; Naumann M; Shastri Y; Povse N; Stein J
Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
[TBL] [Abstract][Full Text] [Related]
17. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.
De Sloovere MMW; De Smet D; Baert FJ; Debrabandere J; Vanpoucke HJM
Clin Chem Lab Med; 2017 Aug; 55(9):1435-1446. PubMed ID: 28076305
[TBL] [Abstract][Full Text] [Related]
18. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
[TBL] [Abstract][Full Text] [Related]
19. What is the faecal calprotectin test?
Drug Ther Bull; 2014 Sep; 52(9):102-4. PubMed ID: 25213590
[TBL] [Abstract][Full Text] [Related]
20. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Nielsen AM
Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
